Cargando…

Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease

Gliflozins (sodium-glucose transporter-2 inhibitors) exhibited renoprotective effects not only in diabetic but also in non-diabetic patients with chronic kidney disease (CKD). Controversial results were reported in experimental non-diabetic models of CKD. Therefore, we examined empagliflozin effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hojná, Silvie, Kotsaridou, Zoe, Vaňourková, Zdeňka, Rauchová, Hana, Behuliak, Michal, Kujal, Petr, Kadlecová, Michaela, Zicha, Josef, Vaněčková, Ivana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599022/ https://www.ncbi.nlm.nih.gov/pubmed/36289772 http://dx.doi.org/10.3390/biomedicines10102509

Ejemplares similares

Renoprotection Provided by Additional Diuretic Treatment in Partially Nephrectomized Ren-2 Transgenic Rats Subjected to the Combined RAS and ET(A) Blockade
por: Vaněčková, Ivana, et al.
Publicado: (2019)

Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein
por: Malínská, Hana, et al.
Publicado: (2022)

Basal and Activated Calcium Sensitization Mediated by RhoA/Rho Kinase Pathway in Rats with Genetic and Salt Hypertension
por: Behuliak, Michal, et al.
Publicado: (2017)

Addition of Endothelin A-Receptor Blockade Spoils the Beneficial Effect of Combined Renin-Angiotensin and Soluble Epoxide Hydrolase Inhibition: Studies on the Course of Chronic Kidney Disease in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats
por: Chábová, Věra Čertíková, et al.
Publicado: (2019)

Contribution of Ca(2+)-Dependent Cl(−) Channels to Norepinephrine-Induced Contraction of Femoral Artery Is Replaced by Increasing EDCF Contribution during Ageing
por: Liskova, Silvia, et al.
Publicado: (2014)

Erratum to “Contribution of Ca(2+)-Dependent Cl(−) Channels to Norepinephrine-Induced Contraction of Femoral Artery Is Replaced by Increasing EDCF Contribution during Ageing”
por: Liskova, Silvia, et al.
Publicado: (2018)

Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension
por: Kala, Petr, et al.
Publicado: (2023)

Renoprotective effects of empagliflozin are linked to activation of the tubuloglomerular feedback mechanism and blunting of the complement system
por: Chen, Xin, et al.
Publicado: (2023)

In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia
por: Hüttl, Martina, et al.
Publicado: (2021)

Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats
por: Kujal, Petr, et al.
Publicado: (2014)

AT(1) receptor blocker, but not an ACE inhibitor, prevents kidneys from hypoperfusion during congestive heart failure in normotensive and hypertensive rats
por: Kratky, Vojtech, et al.
Publicado: (2021)

Editorial: Recent advances on renoprotection and kidney regeneration
por: Gimenez, Ignacio, et al.
Publicado: (2023)

Empagliflozin in Patients with Chronic Kidney Disease
por: Herrington, William G., et al.
Publicado: (2023)

Deleterious Effects of Hyperactivity of the Renin-Angiotensin System and Hypertension on the Course of Chemotherapy-Induced Heart Failure after Doxorubicin Administration: A Study in Ren-2 Transgenic Rat
por: Kala, Petr, et al.
Publicado: (2020)

Hypolipidemic and insulin sensitizing effects of salsalate beyond suppressing inflammation in a prediabetic rat model
por: Hüttl, Martina, et al.
Publicado: (2023)

Impact of empagliflozin on diabetic kidney disease
por: Koya, Daisuke
Publicado: (2017)

Renoprotective effects of garlic
por: Nasri, Hamid
Publicado: (2013)

Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Podoplanin mediates the renoprotective effect of berberine on diabetic kidney disease in mice
por: Yu, Jing, et al.
Publicado: (2019)

Renoprotective role of bariatric surgery in patients with established chronic kidney disease
por: Morales, Enrique, et al.
Publicado: (2020)

Suppressed renoprotective purines in COVID-19 patients with acute kidney injury
por: Jackson, Edwin K., et al.
Publicado: (2022)

Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection
por: Haruhara, Kotaro, et al.
Publicado: (2022)

Disparate Roles of Oxidative Stress in Rostral Ventrolateral Medulla in Age-Dependent Susceptibility to Hypertension Induced by Systemic l-NAME Treatment in Rats
por: Chao, Yung-Mei, et al.
Publicado: (2022)

Renoprotective effect of Tanshinone IIA against kidney injury induced by ischemia-reperfusion in obese rats
por: Tai, He, et al.
Publicado: (2022)

Renoprotective Effects of Solid-State Cultivated Antrodia cinnamomea in Juvenile Rats with Chronic Kidney Disease
por: Tain, You-Lin, et al.
Publicado: (2023)

Dapagliflozin versus empagliflozin in patients with chronic kidney disease
por: Alnsasra, Hilmi, et al.
Publicado: (2023)

Renoprotection and the Bardoxolone Methyl Story – Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents
por: Onuigbo, Macaulay
Publicado: (2013)

Impaired renal autoregulation and pressure-natriuresis: any role in the development of heart failure in normotensive and angiotensin II-dependent hypertensive rats?
por: Honetschlägerová, Zuzana, et al.
Publicado: (2023)

Renoprotective effects of green tea
por: Hajian, Shabnam
Publicado: (2013)

Possible renoprotective effects of dabigatran
por: Karahan, Oğuz
Publicado: (2015)

Early renoprotection by anemia correction
por: Kuriyama, Satoru
Publicado: (2018)

Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018)

Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats
por: Kuno, Atsushi, et al.
Publicado: (2020)

The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan
por: Wang, Yuying, et al.
Publicado: (2016)

Renoprotective effects of a novel cMet agonistic antibody on kidney fibrosis
por: Kim, Yong Chul, et al.
Publicado: (2019)

Renoprotective effects of ferric citrate in a mouse model of chronic kidney disease
por: Hanudel, Mark R., et al.
Publicado: (2022)

Metformin and Canagliflozin Are Equally Renoprotective in Diabetic Kidney Disease but Have No Synergistic Effect
por: Corremans, Raphaëlle, et al.
Publicado: (2023)

Modeling the renoprotective mechanisms of SGLT2 inhibition in hypertensive chronic kidney disease
por: Clemmer, John S., et al.
Publicado: (2023)

Renoprotective activity of sivelestat in severe acute pancreatitis in rats
por: WANG, HOUHONG, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_85u879u21eci2q6d0mgoko2t82